ID   IPMK_HUMAN              Reviewed;         416 AA.
AC   Q8NFU5;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   15-MAR-2017, entry version 119.
DE   RecName: Full=Inositol polyphosphate multikinase;
DE            EC=2.7.1.151;
DE   AltName: Full=Inositol 1,3,4,6-tetrakisphosphate 5-kinase;
GN   Name=IPMK; Synonyms=IMPK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, MUTAGENESIS OF 322-ARG-LYS-323
RP   AND 327-LYS-LYS-328, AND SUBCELLULAR LOCATION.
RX   PubMed=12027805; DOI=10.1042/BJ20020327;
RA   Nalaskowski M.M., Deschermeier C., Fanick W., Mayr G.W.;
RT   "The human homologue of yeast ArgRIII protein is an inositol phosphate
RT   multikinase with predominantly nuclear localization.";
RL   Biochem. J. 366:549-556(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12223481; DOI=10.1074/jbc.M206134200;
RA   Chang S.-C., Miller A.L., Feng Y., Wente S.R., Majerus P.W.;
RT   "The human homolog of the rat inositol phosphate multikinase is an
RT   inositol 1,3,4,6-tetrakisphosphate 5-kinase.";
RL   J. Biol. Chem. 277:43836-43843(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-7, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Inositol phosphate kinase with a broad substrate
CC       specificity. Has a preference for inositol 1,4,5-trisphosphate
CC       (Ins(1,4,5)P3) and inositol 1,3,4,6-tetrakisphosphate
CC       (Ins(1,3,4,6)P4). {ECO:0000269|PubMed:12027805,
CC       ECO:0000269|PubMed:12223481}.
CC   -!- CATALYTIC ACTIVITY: 2 ATP + 1D-myo-inositol 1,4,5-trisphosphate =
CC       2 ADP + 1D-myo-inositol 1,3,4,5,6-pentakisphosphate.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12027805}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous, with the highest expression in
CC       skeletal muscle, liver, placenta, lung, peripheral blood
CC       leukocytes, kidney, spleen and colon.
CC       {ECO:0000269|PubMed:12223481}.
CC   -!- SIMILARITY: Belongs to the inositol phosphokinase (IPK) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF432853; AAM97838.1; -; mRNA.
DR   EMBL; BK000580; DAA01362.1; -; mRNA.
DR   EMBL; BC065709; AAH65709.1; -; mRNA.
DR   CCDS; CCDS7250.1; -.
DR   RefSeq; NP_689416.1; NM_152230.4.
DR   UniGene; Hs.30280; -.
DR   ProteinModelPortal; Q8NFU5; -.
DR   SMR; Q8NFU5; -.
DR   BioGrid; 128968; 1.
DR   IntAct; Q8NFU5; 2.
DR   STRING; 9606.ENSP00000363046; -.
DR   iPTMnet; Q8NFU5; -.
DR   PhosphoSitePlus; Q8NFU5; -.
DR   BioMuta; IPMK; -.
DR   DMDM; 50401072; -.
DR   EPD; Q8NFU5; -.
DR   MaxQB; Q8NFU5; -.
DR   PaxDb; Q8NFU5; -.
DR   PeptideAtlas; Q8NFU5; -.
DR   PRIDE; Q8NFU5; -.
DR   DNASU; 253430; -.
DR   Ensembl; ENST00000373935; ENSP00000363046; ENSG00000151151.
DR   GeneID; 253430; -.
DR   KEGG; hsa:253430; -.
DR   UCSC; uc001jkb.3; human.
DR   CTD; 253430; -.
DR   DisGeNET; 253430; -.
DR   GeneCards; IPMK; -.
DR   HGNC; HGNC:20739; IPMK.
DR   HPA; HPA037837; -.
DR   HPA; HPA057542; -.
DR   MalaCards; IPMK; -.
DR   MIM; 609851; gene.
DR   neXtProt; NX_Q8NFU5; -.
DR   OpenTargets; ENSG00000151151; -.
DR   PharmGKB; PA134903369; -.
DR   eggNOG; KOG1620; Eukaryota.
DR   eggNOG; ENOG410YHQ3; LUCA.
DR   GeneTree; ENSGT00390000014381; -.
DR   HOGENOM; HOG000116306; -.
DR   HOVERGEN; HBG052124; -.
DR   InParanoid; Q8NFU5; -.
DR   KO; K00915; -.
DR   OMA; EVEVRMI; -.
DR   OrthoDB; EOG091G0KJW; -.
DR   PhylomeDB; Q8NFU5; -.
DR   TreeFam; TF321442; -.
DR   BioCyc; MetaCyc:HS07712-MONOMER; -.
DR   BRENDA; 2.7.1.151; 2681.
DR   Reactome; R-HSA-1855191; Synthesis of IPs in the nucleus.
DR   SABIO-RK; Q8NFU5; -.
DR   GenomeRNAi; 253430; -.
DR   PRO; PR:Q8NFU5; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000151151; -.
DR   CleanEx; HS_IPMK; -.
DR   Genevisible; Q8NFU5; HS.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000824; F:inositol tetrakisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0047326; F:inositol tetrakisphosphate 5-kinase activity; TAS:Reactome.
DR   GO; GO:0000825; F:inositol tetrakisphosphate 6-kinase activity; TAS:Reactome.
DR   GO; GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0000823; F:inositol-1,4,5-trisphosphate 6-kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0032958; P:inositol phosphate biosynthetic process; IEA:Ensembl.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0001841; P:neural tube formation; IEA:Ensembl.
DR   InterPro; IPR005522; IPK.
DR   PANTHER; PTHR12400; PTHR12400; 1.
DR   Pfam; PF03770; IPK; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195}.
FT   CHAIN         2    416       Inositol polyphosphate multikinase.
FT                                /FTId=PRO_0000066870.
FT   REGION      140    148       Substrate binding. {ECO:0000250}.
FT   MOTIF       320    330       Nuclear localization signal.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES       7      7       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   VARIANT     349    349       M -> I (in dbSNP:rs2275443).
FT                                /FTId=VAR_022112.
FT   MUTAGEN     322    323       RK->QQ: Interferes with nuclear
FT                                localization.
FT                                {ECO:0000269|PubMed:12027805}.
FT   MUTAGEN     327    328       KK->QQ: Interferes with nuclear
FT                                localization.
FT                                {ECO:0000269|PubMed:12027805}.
SQ   SEQUENCE   416 AA;  47222 MW;  622D678696A892F9 CRC64;
     MATEPPSPLR VEAPGPPEMR TSPAIESTPE GTPQPAGGRL RFLNGCVPLS HQVAGHMYGK
     DKVGILQHPD GTVLKQLQPP PRGPRELEFY NMVYAADCFD GVLLELRKYL PKYYGIWSPP
     TAPNDLYLKL EDVTHKFNKP CIMDVKIGQK SYDPFASSEK IQQQVSKYPL MEEIGFLVLG
     MRVYHVHSDS YETENQHYGR SLTKETIKDG VSRFFHNGYC LRKDAVAASI QKIEKILQWF
     ENQKQLNFYA SSLLFVYEGS SQPTTTKLND RTLAEKFLSK GQLSDTEVLE YNNNFHVLSS
     TANGKIESSV GKSLSKMYAR HRKIYTKKHH SQTSLKVENL EQDNGWKSMS QEHLNGNVLS
     QLEKVFYHLP TGCQEIAEVE VRMIDFAHVF PSNTIDEGYV YGLKHLISVL RSILDN
//
